Phytochemical And Biological Activity Studies On Garcinia Atroviridis Griff. Ex T. Anders. by Tan, Wen Nee
 PHYTOCHEMICAL AND BIOLOGICAL ACTIVITY STUDIES 
ON GARCINIA ATROVIRIDIS GRIFF. EX T. ANDERS. 
 
 
 
by 
 
 
 
TAN WEN NEE 
 
 
 
Thesis submitted in fulfillment of the requirements  
for the degree of  
Doctor of Philosophy 
 
 
 
DECEMBER 2013 
 
 
 
ii 
 
ACKNOWLEDGEMENT 
 
First of all, I am very thankful to my supervisor, Dr. Melati Khairuddean for her 
great assistance and encouragement. Next, I would like to express my sincere 
gratitude to my ex-supervisor, Assoc. Prof. Dr. Wong Keng Chong who has retired in 
the year 2012. Without his valuable guidance and advice, this research would not 
have been successful.  
 
I am grateful to the Dean of the Institute of Graduate Studies (IPS) for giving me a 
chance to pursue my postgraduate studies at USM. Also, I would like to thank the 
Dean of the School of Chemical Sciences, Prof. Dr. Wan Ahmad Kamil Mahmood 
for equipping me with the necessary facilities throughout the research. 
 
I would like to dedicate my appreciation to the Institute of Graduate Studies (IPS) for 
awarding me with the USM Fellowship, and the Ministry of Higher Education, 
Malaysia, for the sponsorship of MyBrain MyPhD, which covered my tuition fees 
and allowance.  
 
I would also like to acknowledge Mr. Baharuddin Sulaiman from the School of 
Biological Sciences, USM for providing me with the plant materials and preparing 
the voucher specimen of the plant.  
 
I am indebted to the technical and laboratory staffs of the School of Chemical 
Sciences, in particular, Mr. Zahari Othman, Mr. Chow Cheng Por, Mr. Mohd. Nazeef, 
iii 
 
Mr. Clement D’Silva, Mr. Megat Hasnul and Mdm. Nurul Arlita for their assistance 
during the course of this study.  
 
I would like to thank Dr. Ibrahim Eldeen, School of Pharmaceutical Sciences, USM, 
Mr. Khaw Kooi Yeong, School of Pharmaceutical Sciences, USM, and Mr. Tong 
Woei Yenn, School of Biological Sciences, USM for their help in the biological 
assays. Thanks also go out to Assoc. Prof. Datin Dr. Rohaya Ahmad, Universiti 
Teknologi MARA, Shah Alam, for her help in recording the CD spectrum. 
 
I would also like to take this opportunity to thank my lab mates and friends, 
particularly Dr. Abdul Hamid, Dr. Yasodha Sivasothy, Dr. Afsheen Wasim, Miss 
Nargis Jamila, Mr. Mohamed Ali Alwahsh, Mr. AbouBaker Elhadi, Miss Chan Yi 
Chen, Miss Alice Wong Yee Yen, Miss Foong Shin Yee, Miss Koay Yen Chin, Mr. 
Faheem Amir, Miss Nadia Rosli, Miss Norhana Mohamed and Miss Nor Shuhada for 
their cooperation and support throughout this research. 
 
Finally, I would like to express my deepest gratitude to my wonderful parents and 
brothers. Thank you for giving me strength, endless love and support throughout my 
life.  
 
 
 
 
 
 
iv 
 
TABLE OF CONTENTS 
          Page 
Acknowledgement           ii 
Table Of Contents          iv 
List Of Tables           ix 
List Of Figures           x 
List Of Schemes                   xiv 
List Of Abbreviations And Symbols                xxii 
List Of Appendices                  xvii 
Abstrak                  xxiii 
Abstract                   xxv 
 
CHAPTER ONE: INTRODUCTION      1 
1.1 Natural Products        1 
1.2 The Clusiaceae Family       1 
1.3 The Genus Garcinia        2 
1.4 Garcinia atroviridis Griff. ex T. Anders. And Its Medicinal Uses  3 
            
CHAPTER TWO: LITERATURE REVIEW     7 
2.1 Previous Studies On Garcinia atroviridis     7 
2.2 Studies On Other Garcinia Species      10 
2.3 Problem Statement        12 
2.4 Objectives Of The Study       13 
2.5 Scopes Of The Study        14 
 
v 
 
CHAPTER THREE: MATERIALS AND METHODS    15 
3.1 Collection Of Plant Material                  15 
3.2 Chemicals And Reagents       15 
3.3 Isolation And Analysis Of Volatile Oil     16 
 3.3.1 Isolation Of Volatile Oil      16
 3.3.2 Gas Chromatographic Analysis Of The Volatile Oil   17
  3.3.2 (a) Gas-Chromatography (GC)     17
  3.3.2 (b) Gas Chromatography-Mass Spectrometry (GC - MS) 19 
 3.3.3 Identification Of The Volatile Oil Components   19
 3.3.4 Chiral Separation Of β-Caryophyllene    20 
 3.3.5 Synthesis Of Authentic Compounds     20 
3.4 Isolation And Characterization Of The Non-Volatile Constituents   22 
 In The  Stem Bark of Garcinia atroviridis      
 3.4.1 Extraction Procedure       22 
 3.4.2 Separation Techniques      23 
 3.4.3 Isolation And Purification      23 
  3.4.3 (a) Hexane Extract      23 
  3.4.3 (b) Dichloromethane Extract     26 
  3.4.3 (c) Chloroform Extract      32 
 3.4.4 Structure Elucidation Of Isolated Compounds   34 
  3.4.4 (a) Melting Point       34 
  3.4.4 (b) Infrared Spectroscopy     34 
  3.4.4 (c) Direct Probe-Mass Spectrometry    34 
  3.4.4 (d) TOF Liquid Chromatography-Mass Spectrometry  34 
  3.4.4 (e) Nuclear Magnetic Resonance Spectroscopy  34 
vi 
 
  3.4.4 (f) Ultraviolet Spectroscopy (UV)    35 
  3.4.4 (g) Circular Dichroism Spectroscopy (CD)   35 
3.5 Biological Activities Of The Volatile Constituents, Crude Extracts   35 
 And Isolated Compounds 
 3.5.1 Antibacterial Activity       35 
 3.5.2 Anti-Inflammatory Activity      36 
  3.5.2 (a) Cyclooxygenase Inhibitor Screening Assay   36 
 3.5.3 Cholinesterase Enzyme Inhibitory Activity    37 
 3.5.4 Antioxidant Activity       38 
  3.5.4 (a) Preparation of Diphenylpicryl-hydrazyl    38 
   (DPPH) Solution 
  3.5.4 (b) Samples Preparation     38 
  3.5.4 (c) DPPH Free Radical Scavenging Assay   38 
 
CHAPTER FOUR: RESULTS AND DISCUSSION    40 
4.1 Volatile Constituents Isolated From The Fruit Of G. atroviridis  40 
 4.1.1 The Yield Of The Volatile Oil     40 
 4.1.2 Identification Of Chemical Constituents Of The Volatile Oil 40 
 4.1.3 Volatile Constituents Of Garcinia atroviridis   40 
 4.1.4 Structural Elucidation Of Volatile Constituents    51 
  4.1.4 (a) Constituent 68      51 
  4.1.4 (b) Constituent 70      54 
  4.1.4 (c) Constituent 71      57 
4.2 Non-Volatile Constituents Isolated From The Stem Bark Of   60 
 G. atroviridis 
vii 
 
 4.2.1 Hexane Extract       60 
  4.2.1 (a) Compound 90      60 
  4.2.1 (b) Compound 91      63 
 4.2.2 Dichloromethane Extract      66 
  4.2.2 (a) Compound 92      66 
  4.2.2 (b) Compound 93                 70 
  4.2.2 (c) Compound 94                 72 
  4.2.2 (d) Compound 95                 75 
  4.2.2 (e) Compound 96                 78 
  4.2.2 (f) Compound 97                 81 
 4.2.3 Chloroform Extract                  84 
  4.2.3 (a) Compound 98                 84 
  4.2.3 (b) Compound 100                 98 
  4.2.3 (c) Compound 101                115 
 
CHAPTER FIVE: BIOLOGICAL ACTIVITY STUDIES             135 
5.1 Evaluation Of The Antibacterial And Anti-Inflammatory              135 
 Activities Of The Volatile Constituents, Cholinesterase  
 Enzymes Inhibitory Activities And Antioxidant Activity  
 Of The Non-Volatile Constituents 
 5.1.1  Volatile Constituents                 135 
  5.1.1 (a) Antibacterial Activity Of The Volatile Oil And             135 
      Three Of Its Constituents 
  5.1.1 (b) Anti-Inflammatory Activity Of The Volatile Oil             137 
      And Three Of Its Constituents 
viii 
 
 5.1.2  Non-Volatile Constituents                139 
  5.1.2 (a) Cholinesterase Enzymes Inhibitory Activities Of             139 
      The Extracts And Non-Volatile Phytochemicals 
  5.1.2 (b) Antioxidant Activity Of The Extracts And              142 
      Non-Volatile Phytochemicals 
 
CHAPTER SIX: CONCLUSION                 144 
 
REFERENCES                   147 
 
LIST OF PUBLICATIONS                  248 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
LIST OF TABLES 
          Page 
Table 4.1 Volatile Constituents Identified In The Fruit Of    41 
  Garcinia atroviridis 
 
Table 4.2  Comparison of 1H-NMR (500 MHz) Data And               89 
  1H-1H COSY Correlations Of Compound 98  
  With Garcinexanthone E In CDCl3 
 
Table 4.3  Comparison of 13C-NMR (125 MHz) Data And               90 
  1H-13C HMBC Correlations Of Compound 98  
  With Garcinexanthone E In CDCl3 
 
Table 4.4  1H-NMR (500 MHz) Data And 1H-1H COSY              103 
  Correlations Of Compound 100 In CD3COCD3 
 
Table 4.5  13C-NMR (125 MHz) Data And 1H-13C HMBC              107 
  Correlations Of Compound 100 In CD3COCD3 
 
Table 4.6 1H-1H NOESY Correlations Of Compound 100              108 
  In CD3OD 
 
Table 4.7  1H-NMR (500 MHz) Data And 1H-1H COSY              122 
  Correlations Of Compound 101 In CD3OD 
 
Table 4.8  13C-NMR (125 MHz) Data And 1H-13C HMBC              125 
  Correlations Of Compound 101 In CD3OD 
 
Table 4.9 1H-1H NOESY Correlations Of Compound 101              127 
  In CD3OD 
 
 
 
 
 
 
 
 
 
x 
 
LIST OF FIGURES 
         Page 
Fig. 1.1 The Parts Of Garcinia atroviridis     4 
     
Fig. 1.2 Garcinia atroviridis Found In Botanical Garden,    5 
  Penang  
 
Fig. 1.3 Garcinia atroviridis Fruit       5 
 
Fig. 4.1 Expanded Gas Chromatogram Of An Authentic    49 
  Mixture Containing (-)-β-Caryophyllene (98.5%)  
  And Its Enantiomer  
 
Fig. 4.2 Expanded Gas Chromatogram Of Coinjection    50 
  Experiments Of The Fruit Volatiles With The  
  Mixture Of (-)-β-Caryophyllene Isomers 
 
Fig. 4.3 Comparison Of Mass Spectra Of Constituent 68    53 
  With Those Found In The Fruit Volatiles And  
  GC-MS Libraries 
 
Fig. 4.4 Comparison Of Mass Spectra Of Constituent 70    56 
  With Those Found In The Fruit Volatiles And  
  GC-MS Libraries 
 
Fig. 4.5 Comparison Of Mass Spectra Of Constituent 71    59 
  With Those Found In The Fruit Volatiles And  
  GC-MS Libraries 
 
Fig. 4.6  FT-IR Spectrum Of Compound 98                85 
 
Fig. 4.7  Mass Spectrum Of Compound 98                86 
 
Fig. 4.8  UV Spectrum Of Compound 98 In MeOH               87 
 
Fig. 4.9  1H-NMR Spectrum Of Compound 98                88 
  (CDCl3, 500 MHz) 
 
Fig. 4.10  1H-1H COSY-NMR Spectrum Of Compound 98               93 
  (CDCl3, 500 MHz) 
 
Fig. 4.11 13C-NMR Spectrum Of Compound 98                94 
  (CDCl3, 125 MHz) 
 
Fig. 4.12  DEPT 135-NMR Spectrum Of Compound 98               95 
  (CDCl3, 125 MHz) 
 
xi 
 
Fig. 4.13  DEPT 90-NMR Spectrum Of Compound 98                          95 
  (CDCl3, 125 MHz) 
 
Fig. 4.14  1H-13C HMQC-NMR Spectrum Of Compound 98                96 
  (CDCl3, 500 MHz) 
 
Fig. 4.15  1H-13C HMBC-NMR Spectrum Of Compound 98                97 
  (CDCl3, 500 MHz) 
 
Fig. 4.16 Key HMBC Correlations Of Compound 98                91 
 
Fig. 4.17 Structure Of 5,10-Dihydroxy-12-(Z)-3-hydroxymethylbuten-           92 
  2-yl-2,2-dimethyl-2H, 6H-pyrano [3,2-b]xanthen-6-one 99 
 
Fig. 4.18  FT-IR Spectrum Of Compound 100                 99 
 
Fig. 4.19  Mass Spectrum Of Compound 100               100 
 
Fig. 4.20  UV Spectrum Of Compound 100 In MeOH              101 
  
Fig. 4.21  1H-NMR Spectrum Of Compound 100              102 
  (CD3COCD3, 500 MHz) 
 
Fig. 4.22  1H-1H COSY-NMR Spectrum Of Compound 100             109 
  (CD3COCD3, 500 MHz) 
 
Fig. 4.23  13C-NMR Spectrum Of Compound 100               110 
  (CD3COCD3, 125 MHz) 
 
Fig. 4.24 DEPT 135-NMR Spectrum Of Compound 100              111 
  (CD3COCD3, 125 MHz) 
 
Fig. 4.25  DEPT 90-NMR Spectrum Of Compound 100              111 
  (CD3COCD3, 125 MHz) 
 
Fig. 4.26  1H-13C HMQC-NMR Spectrum Of Compound 100             112 
  (CD3COCD3, 500 MHz) 
 
Fig. 4.27  1H-13C HMBC-NMR Spectrum Of Compound 100             113 
  (CD3COCD3, 500 MHz) 
 
Fig. 4.28  1H-1H NOESY-NMR Spectrum Of Compound 100             114 
  (CD3COCD3, 500 MHz) 
 
Fig. 4.29 Key HMBC Correlations Of The Partial               199 
  Compound 100 
 
Fig. 4.30 Key HMBC Correlations Of The Partial               199 
  Compound 100 
xii 
 
Fig. 4.31 Key HMBC Correlations Of The Partial               199 
  Compound 100 
 
Fig. 4.32 Selected NOESY Correlations Of The Partial              200 
  Compound 100 
  
Fig. 4.33  FT-IR Spectrum Of Compound 101               116 
 
Fig. 4.34  Mass Spectrum Of Compound 101               117 
 
Fig. 4.35  UV Spectrum Of Compound 101 In MeOH              118 
 
Fig. 4.36(A)  1H-NMR Spectrum Of Compound 101               119 
  (CD3OD, 500 MHz) 
 
Fig. 4.36(B) 1H-NMR Spectrum Of Compound 101              120 
  (CD3COCD3, 500 MHz) 
 
Fig. 4.37  1H-1H COSY-NMR Spectrum Of Compound 101             129 
  (CD3OD, 500 MHz) 
 
Fig. 4.38  13C-NMR Spectrum Of Compound 101               130 
  (CD3OD, 125 MHz) 
 
Fig. 4.39  DEPT 135-NMR Spectrum Of Compound 101              131 
  (CD3OD, 125 MHz) 
 
Fig. 4.40  DEPT 90-NMR Spectrum Of Compound 101              131 
  (CD3OD, 125 MHz) 
 
Fig. 4.41  1H-13C HMQC-NMR Spectrum Of Compound 101             132 
  (CD3OD, 500 MHz) 
 
Fig. 4.42  1H-13C HMBC-NMR Spectrum Of Compound 101             133 
  (CD3OD, 500 MHz) 
 
Fig. 4.43  1H-1H NOESY-NMR Spectrum Of Compound 101             134 
  (CD3OD, 500 MHz) 
 
Fig. 4.44 Key HMBC Correlations Of The Partial               123 
  Compound 101 
 
Fig. 4.45 Key HMBC Correlations Of The Partial               124 
  Compound 101 
 
Fig. 4.46 Key HMBC Correlations Of The Partial               124 
  Compound 101 
 
Fig. 4.47  Selected NOESY Correlations Of The Partial              126 
xiii 
 
  Compound 101 
 
Fig. 4.48  CD Curve Of Compound 101 In CH3CN              128 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
LIST OF SCHEMES 
         Page 
Scheme 4.1 Acid-Catalyzed Rearrangement Of (-)-β-Caryophyllene  45 
  To Give Compound 51 
 
Scheme 4.2 Acid-Catalyzed Rearrangement Of (-)-β-Caryophyllene  45 
  To Give Compound 65 
 
Scheme 4.3 Acid-Catalyzed Rearrangement Of (-)-β-Caryophyllene  46 
  To Give Compound 68 
 
Scheme 4.4 Acid-Catalyzed Rearrangement Of (-)-β-Caryophyllene  46 
  To Give Compound 70 
 
Scheme 4.5 Acid-Catalyzed Rearrangement Of (-)-β-Caryophyllene  47 
  To Give Compound 71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xv 
 
LIST OF ABBREVIATIONS AND SYMBOLS 
 
AChE   Acetylcholinesterase 
BChE   Butyrylcholinesterase 
CC   Column Chromatography 
CD   Circular Dichroism 
COSY   Correlation Spectroscopy 
COX-1  Cyclooxygenase-1 
COX-2  Cyclooxygenase-2 
d   Doublet 
dd   Doublet Of Doublets 
DEPT   Distortionless Enhancement By Polarization Transfer 
DP-MS  Direct Probe Mass Spectrometry 
DPPH   Diphenylpicryl-hydrazyl 
EI-MS   Electron Ionization Mass Spectrometry 
eV   Electron Volt 
FID   Flame Ionization Detector 
FT-IR   Fourier-Transform Infrared 
GC   Gas Chromatography 
GC-MS  Gas Chromatography-Mass Spectrometry 
HMBC  Hetronuclear Multiple Bond Correlation 
HMQC  Heteronuclear Multiple Quantum Correlation 
INT   p-Iodonitrotetrazolium Violet 
IR   Infrared 
J   Coupling Constant 
xvi 
 
MIC   Minimum Inhibitory Concentrations 
m/z   Mass/Charge 
NMR   Nuclear Magnetic Resonance 
MS   Mass Spectrometry 
NOESY  Nuclear Overhauser Enhancement Spectroscopy 
ppm   Part Per Million 
q   Quartet 
RF   Response Factor 
RI   Retention Index 
RT   Retention Time (Minutes) 
s   Singlet 
t   Triplet 
TLC   Thin Layer Chromatography 
UV   Ultra-Violet 
 
    
 
 
 
 
 
 
 
 
 
xvii 
 
LIST OF APPENDICES 
Page 
Appendix A1 Gas Chromatogram Of Garcinia atroviridis               158 
  Fruit Oil On The SPB-1 Column (Isolate 1) 
 
Appendix A2 Gas Chromatogram Of Garcinia atroviridis               159 
  Fruit Oil On The SPB-1 Column (Isolate 2) 
 
Appendix A3 Gas Chromatogram Of Garcinia atroviridis               160 
  Fruit Oil On The HP-5 Column (Isolate 1) 
 
Appendix A4 Gas Chromatogram Of Garcinia atroviridis               161 
  Fruit Oil On The HP-5 Column (Isolate 2) 
 
Appendix A5 Gas Chromatogram Of Garcinia atroviridis               162 
  Fruit Oil On The Supelcowax 10 Column (Isolate 1) 
 
Appendix A6 Gas Chromatogram Of Garcinia atroviridis               163 
  Fruit Oil On The Supelcowax 10 Column (Isolate 2) 
 
Appendix B Gas Chromatogram Of Acid-Catalyzed               164 
  Rearrangement Of β-Caryopyllene 
 
Appendix C Gas Chromatogram Of An Authentic Mixture              165 
  Containing (-)-β-Caryophyllene (98.5%) And  
  Its Enantiomer 
 
Appendix D Gas Chromatogram Of Coinjection Experiments              166 
  Of The Fruit Volatiles With The Mixture Of  
  (-)-β-Caryophyllene Isomers 
 
Appendix E1 1H-NMR Spectrum Of Constituent 68               167 
  (CDCl3, 500 MHz) 
 
Appendix E2 13C-NMR Spectrum Of Constituent 68               168 
  (CDCl3, 125 MHz) 
 
Appendix E3 DEPT 135-NMR Spectrum Of Constituent 68              169 
  (CDCl3, 125 MHz) 
 
Appendix E4 DEPT 90-NMR Spectrum Of Constituent 68              169 
  (CDCl3, 125 MHz) 
 
Appendix E5 1H-13C HMQC-NMR Spectrum Of Constituent 68              170 
  (CDCl3, 500 MHz) 
 
Appendix F1 1H-NMR Spectrum Of Constituent 70               171 
xviii 
 
  (CDCl3, 500 MHz) 
 
Appendix F2 13C-NMR Spectrum Of Constituent 70                172 
  (CDCl3, 125 MHz) 
 
Appendix F3 DEPT 135-NMR Spectrum Of Constituent 70              172 
  (CDCl3, 125 MHz) 
 
Appendix F4 DEPT 90-NMR Spectrum Of Constituent 70              173 
  (CDCl3, 125 MHz) 
 
Appendix F5 1H-13C HMQC-NMR Spectrum Of Constituent 70              174 
  (CDCl3, 500 MHz) 
 
Appendix G1 1H-NMR Spectrum Of Constituent 71               175 
  (CDCl3, 500 MHz) 
 
Appendix G2 13C-NMR Spectrum Of Constituent 71               176 
  (CDCl3, 125 MHz) 
 
Appendix G3 DEPT 135-NMR Spectrum Of Constituent 71              177 
  (CDCl3, 125 MHz) 
 
Appendix G4 DEPT 90-NMR Spectrum Of Constituent 71              177 
  (CDCl3, 125 MHz) 
 
Appendix G5 1H-13C HMQC-NMR Spectrum Of Constituent 71              178 
  (CDCl3, 500 MHz) 
 
Appendix H1 FT-IR Spectrum Of Compound 90               179 
 
Appendix H2 Mass Spectrum Of Compound 90               180 
 
Appendix H3 1H-NMR Spectrum Of Compound 90               181 
  (CDCl3, 500 MHz) 
 
Appendix H4 13C-NMR Spectrum Of Compound 90               182 
  (CDCl3, 125 MHz) 
 
Appendix H5 DEPT 135-NMR Spectrum Of Compound 90              183 
  (CDCl3, 125 MHz) 
 
Appendix H6 DEPT 90-NMR Spectrum Of Compound 90              183 
  (CDCl3, 125 MHz) 
 
Appendix H7 1H-13C HMQC-NMR Spectrum Of Compound 90              184 
  (CDCl3, 500 MHz) 
 
Appendix H8 1H-13C HMBC-NMR Spectrum Of Compound 90              185 
xix 
 
  (CDCl3, 500 MHz) 
 
Appendix H9 1H-1H COSY-NMR Spectrum Of Compound 90              186 
  (CDCl3, 500 MHz) 
 
Appendix I1 FT-IR Spectrum Of Compound 91               187 
 
Appendix I2 Mass Spectrum Of Compound 91               188 
 
Appendix I3 1H-NMR Spectrum Of Compound 91               189 
  (CDCl3:CD3OD (8:2), 500 MHz) 
 
Appendix I4 13C-NMR Spectrum Of Compound 91               190 
  (CDCl3:CD3OD (8:2), 125 MHz) 
 
Appendix I5 DEPT 135-NMR Spectrum Of Compound 91              191 
  (CDCl3:CD3OD (8:2), 125 MHz) 
 
Appendix I6 DEPT 90-NMR Spectrum Of Compound 91              191 
  (CDCl3:CD3OD (8:2), 125 MHz) 
 
Appendix I7 1H-13C HMQC-NMR Spectrum Of Compound 91             192 
  (CDCl3:CD3OD (8:2), 500 MHz) 
 
Appendix I8 1H-13C HMBC-NMR Spectrum Of Compound 91             193 
  (CDCl3:CD3OD (8:2), 500 MHz) 
 
Appendix I9 1H-1H COSY-NMR Spectrum Of Compound 91             194 
  (CDCl3:CD3OD (8:2), 500 MHz) 
 
Appendix J1 FT-IR Spectrum Of Compound 92               195 
 
Appendix J2 Mass Spectrum Of Compound 92               196 
 
Appendix J3 1H-NMR Spectrum Of Compound 92               197 
  (CDCl3, 500 MHz) 
 
Appendix J4 13C-NMR Spectrum Of Compound 92               198 
  (CDCl3, 125 MHz) 
 
Appendix J5 DEPT 135-NMR Spectrum Of Compound 92              199 
  (CDCl3, 125 MHz) 
 
Appendix J6 DEPT 90-NMR Spectrum Of Compound 92              199 
  (CDCl3, 125 MHz) 
 
Appendix J7 1H-13C HMQC-NMR Spectrum Of Compound 92              200 
  (CDCl3, 500 MHz) 
 
xx 
 
Appendix J8 1H-13C HMBC-NMR Spectrum Of Compound 93              201 
  (CDCl3, 500 MHz) 
 
Appendix J9 1H-1H COSY-NMR Spectrum Of Compound 92              202 
  (CDCl3, 500 MHz) 
 
Appendix K1 FT-IR Spectrum Of Compound 93               203 
 
Appendix K2 Mass Spectrum Of Compound 93               204 
 
Appendix K3 UV Spectrum Of Compound 93 In CHCl3              205 
 
Appendix K4 1H-NMR Spectrum Of Compound 93               206 
  (CDCl3, 500 MHz) 
 
Appendix K5 13C-NMR Spectrum Of Compound 93               207 
  (CDCl3, 125 MHz) 
 
Appendix K6 DEPT 135-NMR Spectrum Of Compound 93             208 
  (CDCl3, 125 MHz) 
 
Appendix K7 DEPT 90-NMR Spectrum Of Compound 93               208 
  (CDCl3, 125 MHz) 
 
Appendix K8 1H-13C HMQC-NMR Spectrum Of Compound 93              209 
  (CDCl3, 500 MHz) 
 
Appendix K9 1H-13C HMBC-NMR Spectrum Of Compound 93              210 
  (CDCl3, 500 MHz) 
 
Appendix K10 1H-1H COSY-NMR Spectrum Of Compound 93              211 
  (CDCl3, 500 MHz) 
 
Appendix L1 FT-IR Spectrum Of Compound 94               212 
 
Appendix L2 Mass Spectrum Of Compound 94               213 
 
Appendix L3 UV Spectrum Of Compound 94 In MeOH              214 
 
Appendix L4 1H-NMR Spectrum Of Compound 94               215 
  (CD3COCD3, 500 MHz) 
 
Appendix L5 13C-NMR Spectrum Of Compound 94               216 
  (CD3COCD3, 125 MHz) 
 
Appendix L6 DEPT 135-NMR Spectrum Of Compound 94              217 
  (CD3COCD3, 125 MHz) 
 
Appendix L7 DEPT 90-NMR Spectrum Of Compound 94               217 
xxi 
 
  (CD3COCD3, 125 MHz) 
 
Appendix L8 1H-13C HMQC-NMR Spectrum Of Compound 94              218 
  (CD3COCD3, 500 MHz) 
 
Appendix L9 1H-13C HMBC-NMR Spectrum Of Compound 94             219 
  (CD3COCD3, 500 MHz) 
 
Appendix L10 1H-1H COSY-NMR Spectrum Of Compound 94             220 
  (CD3COCD3, 500 MHz) 
 
Appendix M1 FT-IR Spectrum Of Compound 95               221 
 
Appendix M2 Mass Spectrum Of Compound 95               222 
 
Appendix M3 UV Spectrum Of Compound 95 In MeOH              223 
 
Appendix M4 1H-NMR Spectrum Of Compound 95               224 
  (CD3COCD3, 500 MHz) 
 
Appendix M5 13C-NMR Spectrum Of Compound 95               225 
  (CD3COCD3, 125 MHz) 
 
Appendix M6 DEPT 135-NMR Spectrum Of Compound 95              226 
  (CD3COCD3, 125 MHz) 
 
Appendix M7 DEPT 90-NMR Spectrum Of Compound 95                 226 
  (CD3COCD3, 125 MHz) 
 
Appendix M8 1H-13C HMQC-NMR Spectrum Of Compound 95              227 
  (CD3COCD3, 500 MHz) 
 
Appendix M9 1H-13C HMBC-NMR Spectrum Of Compound 95             228 
  (CD3COCD3, 500 MHz) 
 
Appendix M10 1H-1H COSY-NMR Spectrum Of Compound 95             229 
  (CD3COCD3, 500 MHz) 
 
Appendix N1 FT-IR Spectrum Of Compound 96               230 
 
Appendix N2 Mass Spectrum Of Compound 96               231
    
Appendix N3 UV Spectrum Of Compound 96 In MeOH              232 
 
Appendix N4 1H-NMR Spectrum Of Compound 96               233 
  (CD3COCD3, 500 MHz) 
 
Appendix N5 13C-NMR Spectrum Of Compound 96               234 
  (CD3COCD3, 125 MHz) 
xxii 
 
 
Appendix N6 DEPT 135-NMR Spectrum Of Compound 96              235 
  (CD3COCD3, 125 MHz) 
 
Appendix N7 DEPT 90-NMR Spectrum Of Compound 96              235 
  (CD3COCD3, 125 MHz) 
 
Appendix N8 1H-13C HMQC-NMR Spectrum Of Compound 96              236 
  (CD3COCD3, 500 MHz) 
 
Appendix N9 1H-13C HMBC-NMR Spectrum Of Compound 96             237 
  (CD3COCD3, 500 MHz) 
 
Appendix N10 1H-1H COSY-NMR Spectrum Of Compound 96             238 
  (CD3COCD3, 500 MHz) 
 
Appendix O1 FT-IR Spectrum Of Compound 97               239
     
Appendix O2 Mass Spectrum Of Compound 97               240 
 
Appendix O3 UV Spectrum Of Compound 97 In MeOH              241 
 
Appendix O4 1H-NMR Spectrum Of Compound 97               242 
  (CD3COCD3, 500 MHz 
 
Appendix O5 13C-NMR Spectrum Of Compound 97              243 
  (CD3COCD3, 125 MHz) 
 
Appendix O6 DEPT 135-NMR Spectrum Of Compound 97              244 
  (CD3COCD3, 125 MHz) 
 
Appendix O7 DEPT 90-NMR Spectrum Of Compound 97                244 
  (CD3COCD3, 125 MHz) 
 
Appendix O8 1H-13C HMQC-NMR Spectrum Of Compound 97              245 
  (CD3COCD3, 500 MHz) 
 
Appendix O9 1H-13C HMBC-NMR Spectrum Of Compound 97             246 
  (CD3COCD3, 500 MHz) 
 
Appendix O10 1H-1H COSY-NMR Spectrum Of Compound 97             247 
  (CD3COCD3, 500 MHz) 
 
 
 
 
 
 
 
xxiii 
 
KAJIAN FITOKIMIA DAN AKTIVITI BIOLOGI KE ATAS GARCINIA 
ATROVIRIDIS GRIFF. EX T. ANDERS. 
 
ABSTRAK 
 
Minyak mudah meruap daripada buah Garcinia atroviridis Griff. ex T. Anders. telah 
dipencilkan melalui kaedah penghidrosulingan dan dianalisa dengan kaedah kapilari 
GC dan GC-MS menggunakan tiga turus yang mempunyai kekutuban yang berbeza. 
Minyak mudah meruap mengandungi terutamanya seskuiterpena dengan komponen 
utama (-)-β-kariofilena (23.8 %), alkohol β-kariofilena (15.6 %) dan α-humulena 
(10.7 %). Tiga komponen daripada minyak mudah meruap, iaitu alkohol β-
kariofilena (68), ginsenol (70) dan (1S,2S,5S,8S)-4,4,8-
trimetiltrisiklo[6.3.1.01,5]dodekan-2-ol (71) telah disintesis dan dipencilkan melalui 
kaedah GC preparatif bagi tujuan pengesahan struktur.  
 
Kulit batang G. atroviridis yang dikeringudara telah diekstrak secara berturutan 
menggunakan radas Sokslet, dengan heksana, diklorometana dan metanol. Ekstrak 
metanol kemudiannya diperingkatkan dengan klorofom. Setiap ekstrak ditulenkan 
melalui kaedah kromatografi turus dengan menggunakan gel silika atau Sefadeks 
LH-20 dan memberikan 11 sebatian tulen. Struktur sebatian tersebut telah ditentukan 
secara kaedah spektroskopi seperti FT-IR, 1D NMR, 2D NMR, UV, DP-MS dan 
TOF LC-MS. Stigmasta-5,22-dien-3-ol (90) dan stigmasta-5,22-dien-3-O-β-
glukopiranosida (91) telah dipencilkan daripada ekstrak heksana manakala ekstrak 
diklorometana memberikan 3β-asetoksi-11α,12α-epoksiolenan-28,13β-olida (92), 
2,6-dimetoksi-p-benzokuinon (93), 1,3,5-trihidroksi-2-metoksizanton (94), 1,3,7-
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trihidroksizanton (95), 3,5,7,4’-tetrahidroksiflavon (96) dan 3,5,7,3’,4’-
pentahidroksiflavon (97). Tiga hasil semula jadi yang baru, iaitu, 5,10-dihidroksi-12-
metoksi-2,2-dimetil-2H,6H-pirano[3,2-b]zanten-6-on (98), 3,3’’,4’’’,5,5’’-
pentahidroksi-(4’-7’’)-oksi-7-O-(11,15-dihidroksi-19-okso-13-zantil)biflavon (100) 
dan (2S,2’’S,2’’’’S)-4’’’’’,5,5’’,5’’’’-tetrahidroksi-(4’-7’’, 4’’’-7’’’’)-dioksi-7-O-
(11,17-dihidroksi-19-okso-13-zantil)triflavon (101) telah dipencilkan daripada 
ekstrak klorofom. 
 
Minyak mudah meruap dan tiga komponen daripadanya, ekstrak mentah dan semua 
sebatian yang dipencilkan telah dianalisa untuk aktiviti biologi (antibakteria, 
perencat enzim kolinsterase, antioksidan dan antiradang). Minyak mudah meruap dan 
tiga komponen daripadanya menunjukkan aktiviti antibakteria dan antiradang yang 
baik. Sebatian 97 dan 98 yang dipencilkan daripada kulit batang adalah aktif 
terhadap aktiviti perencat enzim asetilkolinsteras dan butirilkolinsteras, masing-
masing. Mengenai aktiviti perangkap radikal bebas DPPH, sebatian 97 dan 95 telah 
menunjukkan potensi yang baik bagi aktiviti antioksida. 
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PHYTOCHEMICAL AND BIOLOGICAL ACTIVITY STUDIES ON 
GARCINIA ATROVIRIDIS GRIFF. EX T. ANDERS. 
 
ABSTRACT 
 
The volatile oil of the fruit of Garcinia atroviridis Griff. ex T. Anders. was isolated 
by hydrodistillation and analysed by capillary GC and GC-MS, using three columns 
of different polarity. The oil was dominated by sesquiterpenoids, with the most 
abundant components being (-)-β-caryophyllene (23.8 %), β-caryophyllene alcohol 
(15.6 %) and α-humulene (10.7 %). Three of the volatile constituents, β-
caryophyllene alcohol (68), ginsenol (70) and (1S,2S,5S,8S)-4,4,8-
trimethyltricyclo[6.3.1.01,5]dodecan-2-ol (71) were synthesized and isolated by 
preparative GC for authentication purposes.  
 
The air-dried stem bark of G. atroviridis was sequentially extracted in a Soxhlet 
apparatus using hexane, dichloromethane and methanol. The methanol extract was 
then partitioned with chloroform. Each extract was purified by repeated column 
chromatography over either silica gel or Sephadex LH-20, giving 11 pure 
compounds. Their structures were elucidated by spectroscopic methods such as FT-
IR, 1D NMR, 2D NMR, UV, DP-MS and TOF LC-MS. Stigmasta-5,22-dien-3-ol (90) 
and stigmasta-5,22-dien-3-O-β-glucopyranoside (91) were isolated from the hexane 
extract, while the dichloromethane extract gave 3β-acetoxy-11α,12α-epoxyoleanan-
28,13β-olide (92), 2,6-dimethoxy-p-benzoquinone (93), 1,3,5-trihydroxy-2-
methoxyxanthone (94), 1,3,7-trihydroxyxanthone (95), 3,5,7,4’-tetrahydroxyflavone 
(96) and 3,5,7,3’,4’-pentahydroxyflavone (97). Three new natural products, namely, 
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5,10-dihydroxy-12-methoxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one (98), 
3,3’’,4’’’,5,5’’-pentahydroxy-(4’-7’’)-oxy-7-O-(11,15-dihydroxy-19-oxo-13-
xanthyl)biflavone (100) and (2S,2’’S,2’’’’S)-4’’’’’,5,5’’,5’’’’-tetrahydroxy-(4’-7’’, 
4’’’-7’’’’)-dioxy-7-O-(11,17-dihydroxy-19-oxo-13-xanthyl)triflavone (101) were 
isolated from the chloroform extract. 
 
The volatile oil and three of its constituents, crude extracts and all the isolated 
compounds were assayed for biological activities (antibacterial, cholinesterase 
enzyme inhibitory, antioxidant and anti-inflammatory). The volatile oil and three of 
the constituents showed remarkable antibacterial and anti-inflammatory activities. 
Compounds 97 and 98 isolated from the stem bark are active against 
acetylcholinesterase and butyrylcholinesterase enzymes inhibitory activity, 
respectively. Regarding the DPPH free radical scavenging activity, compounds 97 
and 95 were shown to possess remarkable potential for antioxidant acitivity. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Natural Products  
The term ‘natural products’ is applied to materials derived from plants, 
microorganisms, invertebrates and vertebrates, which are fine biochemical factories 
for the biosynthesis of both primary and secondary metabolites. Natural products 
include steroids, terpenoids, fatty lipids and prostaglandins, alkaloids, amino acids, 
proteins, nucleic acids, carbohydrates, insect and plant growth regulators, phenolic 
compounds, natural dyes and pigments, vitamins, hormones, etc. Due to 
multidirectional promising aspects, the interest in natural products continues to this 
very day. The chemical diversity and unique biological activities of a wide variety of 
natural products have propelled many discoveries in chemical and biological 
sciences, and provided therapeutic agents to treat various diseases as well as offered 
leads for the development of valuable medicines. With the advent of improved 
chromatographic separation techniques, the separation of various natural products is 
achieved routinely. Newer spectroscopic techniques such as two-dimensional nuclear 
magnetic resonance spectrocopy, infrared and Raman spectroscopy, X-ray 
crystallography, and mass spectroscopy have simplified the structure elucidation of 
new natural products. 
 
1.2 The Clusiaceae Family 
The Clusiaceae (or Guttiferae) family of trees is naturally distributed in tropical 
zones between the latitudes of 10º north and 10º south and comprises about 40 
genera and 1000 species (Corner, 1988; Pangsuban, Bamroongrugsa, Kanchanapoom, 
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& Nualsri, 2009). Among them, four genera (Garcinia, Calophyllum, Mesua and 
Mammea) and about 120 species are found in Peninsular Malaysia (Corner, 1988). 
Trees or shrubs of this family contain yellow or white resinous latex, and the leaves 
are opposite, simple and mostly entire, with stipules absent (Corner, 1988). The 
flowers are often bright and showy, variously arranged but generally clustered and 
axillary (Corner, 1988). Clusiaceae are all woody plants and the trunks may be 
buttressed, or there may be knee or prop roots (Stevens, 2007). Several species of the 
Clusiaceae family are well-known for their hulls manufacture due to the quality of 
their wood, and for the healing properties of their latex which is used traditionally for 
its effectiveness against dermatoses (Poumale et al., 2011). One unique feature of 
plants in Clusiaceae is the presence of natural, secondary metabolites called 
xanthones (Lim, 2012).  
 
1.3 The Genus Garcinia  
Garcinia is the biggest genus in the family of Clusiaceae, with over 400 species in 
the tropics of Africa and Asia, and about 50 species found in the lowland and 
mountains of Peninsular Malaysia (Corner, 1988; Pangsuban et al., 2009). Garcinia 
are evergreen, lactiferous, and dioecious trees and shrubs, generally of medium 
height and seldom exceeding 18 m (Corner, 1988; Lim, 2012). The flowers are 
singly or in small clusters in the leaf-axils and occasionally in short racemes (Corner, 
1988). The fruit of Garcinia is large, fleshy and often with a rind (Corner, 1988). Of 
the edible Garcinia species, most notable ones from an economic standpoint are 
Garcinia mangostana, dubbed the Queen of fruits, and Garcinia gummi-gutta, source 
of hydroxycitric acid for weight loss (Lim, 2012). 
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The genus Garcinia comprises of a group of medicinal plants with potential 
therapeutic agents (Hemshekhar et al., 2011). The different plant parts such as fruit, 
fruit rind, flowers, leaves, bark and stem have been used globally as an 
ethnomedicine to treat several disorders such as inflammation, oxidative stress, 
microbial infection, cancer and obesity (Hemshekhar et al., 2011).  
 
1.4 Garcinia atroviridis Griff. ex T. Anders. And Its Medicinal Uses 
Garcinia atroviridis Griff. ex T. Anders. (Fig. 1.1) is a medium-sized fruit tree found 
wild in the forest of Peninsular Malaysia, Thailand, Myanmar, India and sometimes 
in a half-cultivated state in villages (Burkill, 1966; Lim, 2012). It is commonly 
known as ‘Asam Gelugor’ in Malaysia or ‘Som-Khaek’ in Thailand (Lim, 2012). 
The tree can grow to a height of 27 m with 70 cm girth and a long trunk. The crown 
of the tree is narrowly conical with numerous slender, terete drooping branches (Lim, 
2012).  
  
The young fruits are green and turn to bright yellow when ripe. They are depressed 
globose, 6 − 10 cm in diameter with broadly sunken concave apex, containing 12 – 
16 ribs and shallow grooves giving it a fluted form with persistent petals and sepals 
and a thick rind. The fruits often separate off into pegs or segments (Lim, 2012). A 
mature fruit can weigh up to 2 kg (Lim, 2012). The fruit contains several flattened 
seeds 1.5 cm long, which are surrounded by acidic, bright orange pulp (Lim, 2012) 
(Fig. 1.2 & 1.3).  
 
G. atroviridis is gynodioecious and is commonly propagated by seeds (Pangsuban et 
al., 2009). The trees begin to flower 5 − 6 years after planting, and maximum fruit 
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yield is usually attained after 6 − 7 years (Pangsuban et al., 2009). The female trees 
produce fruits, while the hermaphrodite trees sometimes bear only a few fruits or 
have no fruit-set (Pangsuban et al., 2009).  
 
Sun-dried slices of the fruits, locally known as ‘asam keping’, are commercially 
available and are popularly used as a seasoning in curries, sour relish, dressing fish 
or stewed in plenty of sugar and eaten (Lim, 2012; Mackeen et al., 2000). The dried 
fruit slices are used to give acidity to cooked dishes in place of tamarind. The dried 
rind is also used in herbal health teas (Lim, 2012). Occasionally, the young leaves are 
used for culinary purposes and as traditional vegetable (Mackeen et al., 2000). In the 
East Coast states of Peninsular Malaysia, fresh fish are steamed with the leaves of G. 
atroviridis to delay spoilage (Mackeen et al., 2000).  
 
 
Fig. 1.1 G. atroviridis Tree Found In Botanical Garden, Penang 
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Fig. 1.2 The Fruit Of Garcinia atroviridis (Corner, 1988) 
 
 
 
Fig. 1.3 Garcinia atroviridis Fruit  
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In folkloric medicine, G. atroviridis has been used as a postpartum medication agent 
as well as an agent to treat earache, throat irritation, cough, dandruff and certain 
stomach aches associated with pregnancy (Amran, Zaiton, Faizah, & Morat, 2009). 
In Peninsular Malaysia, the fruit is used in a lotion made with vinegar, which is 
rubbed upon the abdomen of a woman after confinement (Burkill, 1966). Juice from 
the leaves is given to a woman after childbirth in one of the numerous protective 
preparations which the Malays employ (Burkill, 1966). It is recorded that decoction 
of the leaves and roots is dropped into the ear for earache (Burkill, 1966). In 
Thailand, the dried fruit of G. atroviridis is used for improving blood circulation, as 
an expectorant, treatment of coughs and as laxative (Lim, 2012). 
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Previous Studies On Garcinia atroviridis  
A xanthone, atroviridin (1) was isolated by Kosin et al. (1998) from the chloroform 
extract of the stem bark of G. atroviridis. From the methanol extract of the dried 
roots, a prenylated benzoquinone, atrovirinone (2), and a prenylated depsidone, 
atrovirisidone (3), have been isolated (Permana et al., 2001). In bioassay for 
antimicrobial activity, atrovirinone (2) and atrovirisidone (3) were found to exhibit 
significant inhibitory activity against Staphylococcus aureus and Bacillus cereus 
(both Gram positive) but not against Escherichia coli (Gram negative), Aspergillus 
ochraceus (fungus), and Candida albicans (yeast) at the dose of 10 µg per disk 
(Permana et al., 2001). Whereas in cytotoxic activity assay, only atrovirinone (2) 
showed cytotoxicity toward HeLa cells with an IC50 of 15 µg/mL, which was 
comparable to the standards, Doxorubicin (IC50 11 µg/mL) and Colchicine (IC50 21 
µg/mL) (Permana et al., 2001). In a continuing study on the roots, Permana et al. 
(2003) had identified a prenylated hydroquinone: 4-methylhydroatrovirinone (4) 
from the methanol extract of the plant. This compound was believed to be the 
intermediate involved in the biosynthesis of atrovirinone (2) and atrovirisidone (3) 
(Permana et al., 2003). In addition, cis-14-docosenoic acid (5), morelloflavone (6) 
and its glucosidic derivative, fukugiside (7), were also isolated (Permana et al., 2003). 
Further investigation on the roots, a prenylated depsidone: atrovirisidone B (8) was 
isolated (Permana et al., 2005). In the in vitro cytotoxicity assay, atrovirisidone B (8) 
has shown to be active against human breast cancer (MCF-7), human prostate cancer 
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(DU-145) and human lung cancer (H-460) cell lines. Besides, naringenin (9) and 
3,8’’-binaringenin (10) were also isolated in the same study (Permana et al., 2005).  
 
Previous studies on the fruits have reported the isolation of garcinia acid (identical to    
(-)-hyroxycitric acid) (11), and its dibutyl methyl esters, and β- and γ-lactone 
derivatives, as well as the identification of several saturated fatty acids such as 
pentadecanoic, octadecanoic, nonadecanoic and dodecanoic acids by gas 
chromatography-mass spectrometry (Permana et al., 2001; Jena, Jayaprakasha, Singh 
& Sakariah, 2002; Amran et al., 2009; Lim, 2012). The fruit also contains fruit acids 
such as citric acid (12), tartaric acid (13) and ascorbic acid (14) that have antioxidant 
properties (Amran et al., 2009). The hydroxycitric acid and flavonoids present in the 
fruit extract have been reported to exhibit hypolipidemic activity that can promote 
weight loss, by lowering lipogenesis and increasing glycogen development, thus 
lowering appetite (Amran et al., 2009). 
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2.2 Studies On Other Garcinia Species 
A well-known species from the genus Garcinia is Garcinia mangostana L., 
commonly known as mangosteen. This tropical fruit tree is extensively distributed in 
Southeast Asia (Obolskiy, Pischel, N.Siriwatanametanon, & Heinrich, 2009; Zhang, 
Song, Hao, Qiu, & Xu, 2010). Phytochemical investigations on Garcinia 
mangostana have led to the isolation of xanthone-type compounds as the major 
secondary metabolites (Chin & Kinghorn, 2008). Xanthones, a class of polyphenolic 
compounds with the skeleton of a xanthen-9-one, have been isolated from the 
pericarp, whole fruit, bark, and leaves of G. mangostana (Pedraza-Chaverri, 
Cardenas-Rodriguez, Orozco-Ibarra, & Perez-Rojas, 2008; Obolskiy et al., 2009). 
Studies on the pericarp of the mangosteen fruit have afforded α-mangostin (15) 
(Schmid, 1855; Dragendorff, 1930; Murakami, 1932; Yates & Stout, 1958), β-
mangostin (16) (Dragendorff, 1930; Yates & Bhat, 1968), γ-mangosteen (17) 
(Jefferson, Quillinan, Scheinmann, & Sim, 1970), gartanin (18) (Govindachari, 
Kalyanaraman, Muthukumaraswamy, & Pai, 1971) and 8-deoxygartanin (19) 
(Govindachari et al., 1971) as the most abundant representatives. Recently, 
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garcimangosxanthone A (20), B (21) and C (22) were isolated from the pericarp of 
Garcinia mangostana (Zhang et al., 2010). Among them, garcimangosxanthone A 
(20) and B (21) were reported to exhibit in vitro cytotoxicity against human lung 
cancer (A549), human pulmonary carcinoma (LAC) and human hepatoma (A375) 
cell lines with IC50 values of 5.7 − 24.9 µM, which were comparable to those of 
Doxorubicin (Zhang et al., 2010). From the ethanol extract of the stem bark of 
Garcinia mangostana, a xanthone, mangosharin (23) has been isolated (Ee, Daud, 
Taufiq-Yap, Ismail, & Rahmani, 2006).  
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Garcinia griffithii T. Anders. is a moderate-size tree found in Peninsular Malaysia 
(Burkill, 1966). Griffipavixanthone (24), a novel bixanthone, has been isolated from 
its bark (Xu et al., 1998). This compound showed high in vitro cytotoxicity against 
P388, LL/2 and Wehi 164 cell lines. In a continuing study on the stem bark of 
Garcinia griffithii, Nilar et al. (2005) had isolated a polyisoprenylated benzophenone, 
guttiferone I (25). 
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2.3 Problem Statement 
Reported investigations on Garcinia species have shown that this genus is rich with 
many pharmacologically and medicinally important chemical entities. The isolated 
compounds from different plant parts of genus Garcinia have been widely studied 
for their various therapeutic and pharmacological activities such as antioxidant, anti-
inflammatory, anti-bacterial, anti-viral, anti-protozoan, anti-ulcer, anti-cancer and 
hypolipidemic properties (Hemshekhar et al., 2011).  
 
However, there is lack of information from G. atroviridis on its volatile and non-
volatile constituents though this plant is widely found in Peninsular Malaysia. There 
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is a need to examine the constituents present in G. atroviridis in an attempt to 
discover new natural products that may possess important biochemical and 
pharmacological effects. 
 
2.4 Objectives Of The Study 
The objectives of this study are divided into three parts. The first part is to identify 
the volatile constituents from the fruits of Garcinia atroviridis. The second part is to 
isolate and characterize the non-volatile constituents from the stem barks of G. 
atroviridis. The final part is the biological activity studies including antibacterial, 
cholinesterase enzyme inhibitory, antioxidant and anti-inflammatory. 
1. To identify and quantify the volatile flavour components of the fruit of 
 Garcinia atroviridis using capillary GC and GC-MS techniques. 
2. To synthesize the authentic flavour components, namely, β- caryophyllene 
 alcohol (68), ginsenol (70) and (1S,2S,5S,8S)-4,4,8-
 trimethyltricyclo[6.3.1.01,5]dodecan-2-ol (71). 
3. To isolate and elucidate the structures of the non-volatile constituents in the 
stem bark of Garcinia atroviridis, using various spectroscopic techniques 
(FT-IR, 1D and 2D NMR, UV, DP-MS and TOF LC-MS). 
4. To assay the fruit volatile constituents, all plant extracts and isolated pure 
 components for biological activities (antibacterial, cholinesterase enzyme 
 inhibitory, antioxidant and anti-inflammatory).  
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2.4 Scopes Of The Study 
The samples for this study are the fruits and stem barks of G. atroviridis which were 
collected from Kedah, where a voucher specimen USM 11201 was deposited. 
Identitification of volatile constituents was carried out by hydrodistillation using 
Clevenger apparatus. Sequentially solvent extraction using Soxhlet was used to 
obtain a series of plant extracts. Fractionation and purification of the extracts using 
thin layer chromatography (TLC) and column choromatography (CC) gave pure 
compounds. The structural elucidation of pure compounds is confirmed using 
analytical and spectroscopic methods including FT-IR, 1D and 2D NMR, UV, DP-
MS and TOF LC-MS. The biological activity assays such as antibacterial, 
cholinesterase enzyme inhibitory, antioxidant and anti-inflammatory were performed 
on the volatile oils, crude extracts and pure compounds. 
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CHAPTER THREE 
MATERIALS AND METHODS 
 
3.1 Collection Of Plant Material 
The fruits and stem barks of G. atroviridis were collected in August 2009 from 
Kedah, Malaysia and identified by Mr. Baharuddin Sulaiman from the School of 
Biological Sciences, Universiti Sains Malaysia. A voucher specimen (USM 11201) 
has been deposited at the herbarium of Universiti Sains Malaysia, Penang, Malaysia. 
 
3.2 Chemicals And Reagents 
Chloroform-D1, with 0.03 vol. % TMS, deuteration degree min. 99.8 % for NMR 
spectroscopy (stabilized with silver) (Merck, Germany), Methanol-D4, deuteration 
degree min. 99.8 % for NMR spectroscopy (Merck,  Germany), Acetone-D6, 
deuteration degree min. 99.9 % for NMR spectroscopy (Merck, Germany), Hexane, 
AR grade (QReC, Malaysia), Chloroform, AR and HPLC grade (QReC, Malaysia), 
Dichloromethane, AR grade (QReC, Malaysia), Ethyl acetate, AR grade (QReC, 
Malaysia), Acetone, AR grade (QReC, Malaysia), Methanol, AR and HPLC grade 
(QReC, Malaysia), DMSO, AR Grade (QReC, Malaysia), Ethanol 99.7 %, AR grade 
(QReC, Malaysia), *Pentane, AR grade (QReC, Malaysia), Sephadex LH-20 (Sigma-
Aldrich, USA), Silica Gel 60 for column chromatography, (0.040 - 0.063 mm), (230 
- 400 mesh ASTM) (Merck, Germany), TLC aluminium sheets, Silica Gel 60 F254, 
20cm × 20cm (Merck, Germany), Indomethacin (Sigma-Aldrich, USA), p-
Iodonitrotetrazolium violet (Sigma-Aldrich, USA), Gentamicin sulphate (Sigma-
Aldrich, USA), Nutrient Broth (Merck, Germany), Cyclooxygenase (COX) inhibitor 
screening assay kit (No. 560131; Cayman  Chemical, USA), Acetylthiocholine 
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iodide (Sigma-Aldrich, USA), S-butyrylthiocholine chloride (Sigma-Aldrich, USA), 
Dithiobisnitrobenzoate (Sigma-Aldrich, USA), Physostigmine (Sigma-Aldrich, 
USA), Sodium hydrogen phosphate (R&M Chemical, UK), Disodium hydrogen 
phosphate (R&M Chemical, UK), DPPH free radical (Sigma-Aldrich, USA), 
Ascorbic Acid (Sigma-Aldrich, USA), Arachidonic Acid (Sigma-Aldrich, USA) 
* Solvent was distilled prior to use 
 
3.3 Isolation And Analysis Of Volatile Oil 
3.3.1 Isolation Of Volatile Oil 
Freshly-picked fruits were subjected to hydrodistillation to isolate the volatile oil, 
which was carried out using an all-glass apparatus similar to that described in the 
British Pharmacopoaeia (British Pharmacopoeia, 1993). 
 
The fruits were washed with distilled water and their seeds removed. The rind and 
pulp (850 g) were cut into small pieces and pulverized for 30 s in a blender, after the 
addition of 450 mL of distilled water. The resultant puree was placed in a 2 L round 
bottom flask. Ice-cold water was circulated through the condenser during the 
hydrodistillation process. Hydrodistillation was carried out for 5 hours. A small 
volume of distilled pentane was added from time to time to ensure that the volume of 
pentane was maintained at about 5 mL. 
 
At the end of the hydrodistillation process, the glass apparatus was left to cool and 
the volatile oil solution in pentane was drained through the stop cock into a 
separatory funnel where water was removed. The resulting solution was collected 
into a glass vial (5 mL), concentrated to an appropriate concentration by a gentle 
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stream of nitrogen gas at room temperature, and stored in the refrigerator until 
required for GC and GC-MS analyses. 
 
3.3.2 Gas Chromatographic Analysis Of The Volatile Oil 
The volatile oil isolated from the fruits was analysed by capillary gas 
chromatography (GC) and gas chromatography-mass spectrometry (GC-MS). 
 
3.3.2 (a) Gas Chromatography (GC) 
GC analysis was carried out using a Thermo-Finnigan instrument equipped with a 
flame ionization detector (FID). Three fused silica capillary columns of different 
polarity were employed: SPB-1 (bonded poly(dimethylsiloxane), 30 m × 0.25 mm 
i.d., film thickness, 0.25 µm), HP-5 (bonded poly(5% diphenyl/95% 
dimethylsiloxane), 30 m × 0.32 mm i.d., film thickness, 0.25 μm) and Supelcowax 
10 (bonded poly(ethylene glycol), 30 m × 0.25 mm i.d., film thickness, 0.25 μm). 
The operating conditions of the three columns were as follows: initial oven 
temperature, 40°C for 1 min, then to 220°C at 5°C/min and held for 10 min; injector 
port and detector temperatures, 250°C; carrier gas, 2.0 mL/min He; injection volume, 
0.4 µL; split ratio, 30:1. Peak areas were obtained with a Hitachi D2500 Chromato-
Integrator.  
 
The peak area percentages of individual components were the average values of two 
separate injections of the isolates, one from each of the two samples obtained from 
two independent extractions, while the absolute amounts of the components were 
calculated from the peak area percentages, taking into consideration the response 
factors of the FID for these compounds (Rome & McIntyre, 2012). For the 
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determination of the response factors needed for the calculation of the absolute 
amounts of the selected components, a solution in pentane containing known weights 
of (-)-β-caryophyllene, α-humulene, β-selinene, α-selinene, β-caryophyllene alcohol, 
humulol, ginsenol, (1S,2S,5S,8S)-4,4,8-trimethyltricyclo[6.3.1.01,5]dodecan-2-ol, 
tetradecanoic acid, hexadecanoic acid and internal standards (pentadecane, (-)-
globulol, octadecanoic acid) was injected under the same analytical conditions in a 
separate experiment. For some of the other components which were sesquiterpenes, 
semi-quantitative determination of their absolute amounts was carried out, using 
pentadecane as the internal standard, without considering the calibration factors. The 
experimental retention indices (RIs) were calculated relative to those of n-alkanes, a 
mixture containing a homologous series C5 − C32, which was injected immediately 
after GC analysis of volatile oil under identical operating conditions. 
 
For a temperature-programmed GC, the retention index (RI) of a component in the 
volatile oil was calculated using the following equation (Dool & Kratz, 1963): 
 
  RI = 100 i          t - t(n)            + 100 n     
                          t(n+i) - t(n) 
 
under the condition that t(n) < t < t(n+i). 
 
 t = retention time of a volatile oil component. 
 t(n) = retention time of the alkane with n carbon atoms which was 
   eluted just before the component. 
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 t(n+i) = retention time of the alkane with (n+i) carbon atoms which  
   was eluted just after the component. 
 i = difference in the number of carbon atoms between the two  
   alkanes. 
 n = the number of carbon atoms in the alkane. 
          
and this was used to calculate the RI values in the present work. 
 
3.3.2 (b) Gas Chromatography - Mass Spectrometry (GC-MS) 
GC-MS analysis was performed using a Perkin-Elmer Clarus 600T equipped with the 
Wiley 8th and NIST 08 libraries. The same capillary columns and GC operating 
conditions were employed as described in Section 3.3.2.1.  The injection port was set 
at 250°C. Significant quadrupole MS operating parameters were as follows: interface 
temperature, 250°C; electron impact ionization at 70 eV with scan mass range of 28 
− 400 m/z at a sampling rate of 1.0 scan/s. 
 
3.3.3 Identification Of The Volatile Oil Components 
The components of volatile oil were identified by comparison of their mass spectra 
and retention indices with those of commercially available standards or compounds 
synthesized by established methods. For some constituents, standards were 
unavailable for positive identification. These compounds were identified by 
matching their mass spectra with those recorded in the Wiley 8th and NIST 08 
libraries, and also by comparing the retention indices of these components with 
published data (Adams, 2001). 
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3.3.4 Chiral Separation Of β-Caryophyllene 
The correct β-caryophyllene isomer in the volatile oil was determined by GC and 
GC-MS using a Gamma-Dex™ capillary column (non-bonded; 25% 2,3-di-O-
methyl-6-O-TBDMS-γ-cyclodextrin in SPB-20 poly(20% diphenyl/80% 
dimethylsiloxane) phase, 30 m × 0.25 mm i.d., film thickness, 0.25 μm; Supelco Inc.). 
GC-FID analysis was carried out using a Thermo Finnigan instrument. The operating 
conditions of the column in GC were as follows: initial oven temperature, 40°C for 1 
min, then to 220°C at 5°C/min and held for 10 min; injector port and detector 
temperatures, 250°C; carrier gas, 2.0 mL/min He; injection volume, 0.4 μL; split 
ratio, 30:1. Peak areas were obtained with a Hitachi D2500 Chromato-Integrator. 
GC-MS analysis was performed using a Perkin-Elmer Clarus 600 T with the same 
capillary GC conditions as described above. The injection port was set at 250°C. 
Significant quadrupole MS operating parameters were as follows: interface 
temperature, 250°C; electron impact ionization at 70 eV with scan mass range of 28 
− 400 m/z at a sampling rate of 1.0 scan/s.  
 
3.3.5 Synthesis Of Authentic Compounds 
The authentic compounds (68, 70 and 71) were prepared by the acid-catalysed 
rearrangement of (-)-β-caryophyllene according to the procedure of Fitjer et al. 
(1995). A solution of 96 % sulfuric acid (0.78 mL) in ether (5 mL) was added to a 
solution of (-)-β-caryophyllene (1.11 mL, purity ≥ 98.5 %) in ether (5 mL) at 0 °C 
with stirring. The mixture was allowed to warm to room temperature. A saturated 
solution of sodium bicarbonate (30 mL) was added after 30 min. The mixture was 
then extracted with ether (3 × 30 mL), the combined ether layers were dried with 
MgSO4 anhydrous, and the solvent was evaporated (bath temperature 20 °C) to yield 
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a colourless oil (1.2 g). Constituents 68, 70 and 71 were isolated from the mixture by 
preparative GC using a Shimadzu gas chromatograph equipped with a glass column 
(2.1 m × 3.2 mm i.d.) packed with 10 % Carbowax 20M on Chromosorb WAW 
DMCS 80/100 (Supelco Inc.) and operated isothermally at 220°C with N2 at 50 
mL/min as carrier gas.  
 
(68). 1H NMR (500 MHz, CDCl3): δ 2.21 − 2.27 (m, H2), 1.80 − 1.85 (m, H10), 1.74 
− 1.79 (m, H5), 1.64 − 1.79 (m, H5, H15), 1.58 − 1.63 (m, H4), 1.53 − 1.56 (m, H1), 
1.50 − 1.52 (m, H8, H9), 1.46 − 1.49 (m, H1), 1.34 − 1.38 (m, H6), 1.30 − 1.33 (m, 
H9), 1.28 − 1.29 (m, H4), 1.10 − 1.14 (m, H8), 1.07 (d, J = 5.0 Hz, H6), 1.02 − 1.05 
(m, H15), 1.01 (s, H12), 1.00 (s, H13), 0.89 (s, H14). 13C NMR (125 MHz, CDCl3): 
δ 71.14 (C, C3), 48.72 (CH2, C15), 44.79 (CH, C10), 39.54 (CH, C2), 38.58 (CH2, 
C4), 37.45 (CH2, C6), 36.65 (CH2, C8), 34.97 (C, C7), 34.80 (C, C11), 34.45 (CH2, 
C1), 33.25 (CH3, C14), 30.53 (CH3, C12), 21.93 (CH2, C9), 20.86 (CH2, C5), 20.82 
(CH3, C13). Results for the 1H and 13C NMR are in good agreement with data 
reported for this compound (Rocha, Rodrigues, Kozhevnikov, & Gusevskaya, 2010). 
Mass spectrometry, m/z %: 222 (M+, 1), 166 (100), 123 (49), 85 (30), 95 (29), 81 
(29), 41 (27), 55 (23), 135 (23), 93 (22), 137 (22). 
 
(70). 1H NMR (500 MHz, CDCl3): δ 1.99 (d, J = 14.0 Hz, H2), 1.93 − 1.96 (m, H5), 
1.82 − 1.87 (m, H9), 1.79 − 1.82 (m, H10), 1.76 − 1.79 (m, H10, H6), 1.70 (d, J = 
14.0 Hz, H2), 1.55 − 1.61 (m, H6), 1.48 − 1.53 (m, H5), 1.38 − 1.45 (m, H4, H8, H9), 
1.27 (s, H12), 1.20 (s, H15), 1.16 (dd, J = 5.0, 12.0 Hz, H8), 1.04 (s, H13), 0.87 (s, 
H14). 13C NMR (125 MHz, CDCl3): δ 83.27 (C, C1), 57.15 (CH, C4), 48.06 (CH2, 
C2), 45.39 (C, C11), 38.34 (C, C7), 35.48 (C, C3), 34.56 (CH2, C6), 34.48 (CH2, 
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C8), 34.34 (CH3, C12), 33.62 (CH2, C10), 29.15 (CH3, C15), 28.59 (CH3, C13), 
26.29 (CH2, C5), 24.65 (CH3, C14), 21.86 (CH2, C9). Results for the 1H and 13C 
NMR are in good agreement with data reported for this compound (Iwabuchi, 
Yoshikura, & Kamisako, 1988). Mass spectrometry, m/z %: 222 (M+, 1), 207 (100), 
123 (26), 41 (20), 43 (17), 95 (16), 55 (16), 69 (14), 109 (14), 125 (14), 81 (13). 
 
(71). 1H NMR (500 MHz, CDCl3): δ 3.76 (dd, J = 6.0, 10.0 Hz, H2), 1.73 (dd, J = 
6.0, 12.0Hz, H3), 1.59 − 1.63 (m, H6), 1.50 (dd, J = 10.0, 12.0 Hz, H3), 1.41 − 1.43 
(m, H10), 1.37 − 1.39 (m, H5, H6, H9), 1.21 − 1.29 (m) (m, H7, H9, H10, H11), 1.18 
(d, J = 12.0 Hz, H12), 1.04 (s, H13), 1.01 (d, J = 5.0 Hz, H11), 0.98 (d, J = 12.0 Hz, 
H12), 0.89 (s, H14), 0.86 (s, H15). 13C NMR (125 MHz, CDCl3): δ 81.37 (CH, C2), 
50.88 (CH, C5), 47.81 (CH2, C3), 44.64 (C, C1), 43.17 (CH2, C12), 40.61 (CH2, 
C11), 37.36 (C, C4), 33.45 (CH2, C9), 32.99 (CH3, C14), 32.02 (CH2, C7), 31.68 
(CH3, C13), 30.15 (C, C8), 25.67 (CH3, C15), 20.82 (CH2, C10), 19.11 (CH2, C6). 
Results for the 1H and 13C NMR are in good agreement with data reported for this 
compound (Fitjer et al., 1995). Mass spectrometry, m/z %: 222 (M+, 1), 166 (100), 
123 (49), 85 (30), 95 (29), 81 (29), 41 (27), 55 (23), 135 (23), 93 (22), 137 (22). 
 
3.4 Isolation And Characterization Of The Non-Volatile Constituents In The 
 Stem Bark of Garcinia atroviridis. 
3.4.1 Extraction Procedure 
Air-dried stem bark of G. atroviridis (6.00 kg) was ground and sequentially extracted 
in a Soxhlet apparatus with hexane, dichloromethane and methanol. The resulting 
extracts were evaporated to dryness at 40°C under reduced pressure, using a rotary 
evaporator, to afford greenish-yellow hexane extract (18.00 g), a brown 
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dichloromethane extract (17.00 g) and a reddish-brown methanol extract (100.00 g). 
The methanol extract was then partitioned with chloroform to give a dark brown 
chloroform extract (17.00 g). 
 
3.4.2 Separation Techniques 
Preliminary investigation of the chromatographic separation of the crude extracts 
was carried out using TLC silica gel 60 F254 (5 cm × 2 cm). Different solvent system 
was tested to find the one with the best separation for each of the mixtures. The 
selected solvent systems were utilized later in the column chromatographic 
separation of the crude extracts to isolate the components. Developed TLC plates 
were visualized using a UV lamp (365 nm), or dipped in reagents such as 1 % FeCl3 
(heating not required), or 5 % methanolic H2SO4, followed by heating at 100 − 
105 °C until full development of colour has occurred to aid visualization. 
 
Column chromatography using either silica gel or Sephadex LH-20 was employed 
for component isolation or purification. When silica gel was used as the adsorbent, 
elution was carried out using either isocratic or gradient solvent systems. In the case 
of Sephadex LH-20, methanol was used. Eluates were collected in fractions and the 
composition of each fraction was monitored by TLC. Fractions showing similar TLC 
profiles were pooled, and the solvents were evaporated off. Repeated purification 
using the same technique was carried out until a pure compound was isolated. 
 
3.4.3 Isolation And Purification 
3.4.3 (a) Hexane Extract 
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The hexane extract (15.00 g) was chromatographed on a silica gel column. Elution 
was carried out using solvents of hexane:choloroform / chloroform:ethyl acetate / 
ethyl acetate:methanol gradient system to afford 50 fractions (H1 − H50). The solid 
from fraction H15 (0.35 g) was recrystallised from methanol:chloroform (1:1) to 
yield 90 (20 mg). Fraction H20 (0.25 g) was rechromatographed on a silica gel 
column, eluted successively using solvents of hexane:chloroform / 
chloroform:methanol gradient system to afford 8 major fractions H20A − H20F. 
Fraction H20D (0.03 g) was further purified by silica gel column using an isocratic 
solvent system of chloroform:methanol (9:1) (v/v) to yield 91 (15 mg).  
 
Hexane Extract (15.00 g) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CC 
Hexane:Chloroform/ 
Chloroform:Ethyl Acetate/ 
Ethyl Acetate:Methanol 
50 Fractions 
(H1—H50) 
H15 (0.35 g) H20 (0.25 g) 
Recrystallisation 
MeOH:CHCl3 
(1:1) (v/v) 
 
90 (20 mg) 
CC 
Hex:CHCl3/ 
CHCl3:MeOH 
8 Fractions 
(H20A—H20F) 
H20D (0.03 g) 
CC 
CHCl3:MeOH 
(9:1) (v/v) 
91 (15 mg) 
